Vaccinex, Inc. (VCNX) Operating cash flow 2017–2024
Vaccinex, Inc. (VCNX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$16.2MFY2024 · since FY2017: -$21.4M → -$16.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$16.2M | +24.3% |
| FY2023 | -$21.4M | -12.1% |
| FY2022 | -$19.1M | +24.6% |
| FY2021 | -$25.3M | +11.7% |
| FY2020 | -$28.6M | +6.7% |
| FY2019 | -$30.7M | -21.5% |
| FY2018 | -$25.3M | -18.2% |
| FY2017 | -$21.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VCNX financial trends
VCNX RevenueVCNX Net incomeVCNX Net marginVCNX Gross profitVCNX Gross marginVCNX Operating incomeVCNX Operating marginVCNX Free cash flowVCNX Capital expendituresVCNX Return on equityVCNX Stock buybacksVCNX Dividends paidVCNX Total assetsVCNX Total liabilitiesVCNX Shareholders’ equityVCNX overview →